Global Sum uplift 2025/264%
£242.013m Global Sum, with the £9.31m uplift allocated to the Dispensing Pool.
Guaranteed Minimum£120m
Retained margin guaranteed for 2025/26, up £10m.
Drug Tariff mapping£100m
Part 7 funding mapped as guaranteed income, up £20m.
Total guaranteed£343.313m
Total guaranteed funding for 2025/26.
New deal 2026/27
PCA(P)(2026) 17 (25 September 2026) sets out the headline package for 2026/27. The breakdown for each payment line will follow, and these pages will be updated when it is published.
| 2025/26 | 2026/27 | |
|---|---|---|
| Global Sum | £242.013m | £250.483m (+3.5%) |
| Non-Global Sum | £1.3m | £1.3m |
| Part 7 mapping as guaranteed income | £100m | £110m (+£10m to the Dispensing Pool) |
| Total guaranteed funding | £343.313m | £361.78m |
| Guaranteed Minimum Income | £120m | £130m |
| Post Registration Foundation | £2m | £2m (deadline extended to 30 September 2026) |
Also new: Repayment of the 2023 advance starts when margin exceeds £150m. Margin sharing between NHS Boards and pharmacy owners starts on a 50:50 basis when margin exceeds £160m.
About the agreement
The package sets a defined amount of funding for core services, the Global Sum, which every contractor benefits from. Some smaller elements of national funding sit outside it, the Non-Global Sum, such as stoma dispensing and access to Medicines Complete, which are standalone contracts.
Global Sum
Visual breakdown
The pools named in PCA(P)(2025) 18 total £341.615m. Hover over the chart or the list to see each line.
Non-Global Sum and other arrangements
Sources: Scottish Government circulars PCA(P)(2025) 18 (8 July 2025) and PCA(P)(2026) 17 (25 September 2026).
Community Pharmacy Scotland - Financial Framework 2025-26
